Jefferies Raises PT On Cepheid To $35
Jefferies & Company has raised the price target on Cepheid (NASDAQ: CPHD) from $30 to $35 and maintains its Buy rating.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted-In: cepheid Jefferies & CompanyPrice Target Analyst Ratings